The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoral Products Regulatory News (CRU)

Share Price Information for Coral Products (CRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.60
Bid: 9.20
Ask: 10.00
Change: -0.15 (-1.54%)
Spread: 0.80 (8.696%)
Open: 9.75
High: 9.75
Low: 9.50
Prev. Close: 9.75
CRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half yearly report six months ended 31 Oct 2021

29 Nov 2021 07:55

RNS Number : 8530T
Coral Products PLC
29 November 2021
 

CORAL PRODUCTS PLC

("Coral" or the "Group")

 

HALF YEARLY REPORT

 

Coral Products plc, a specialist in the design, manufacture and supply of plastic products, is pleased to report its half yearly report for the six months ended 31 October 2021.

 

 

Financial headlines

 

 

Six months to

31 October

2021

Six months to

31 October

2020

restated

% change

Group sales

 £7.1 million

 £4.5 million

57.8%

Gross profit

 £2.5 million

 £1.7 million

47.1%

Gross profit margin

 35.7%

 38.0%

-6.1%

Underlying operating profit (excluding finance expenses)*

 £759,000

 £563,000

34.8%

Reported profit before taxation

£510,000

 £ 286,000

78.3%

Underlying EBITDA*

£1,014,000

£771,000

31.5%

Underlying basic earnings per share*

 0.81p

 0.60p

35.0%

Interim dividend per share

0.50p

0.50p

 

\* The financial headlines disclosed as underlying represent the reported metrics excluding separately disclosed items (being share based payment charges, amortisation of intangible assets and other one-off costs in each period), see note 7.

 

Operational and financial highlights 

 

- Strong net assets position has been maintained.

 

- Interim dividend of 0.5p declared.

 

- Cash and cash equivalents of £5.5m (2020: £1.3m). Cash and cash equivalents are defined as cash of £4.8m (2020: £1.3m) plus treasury shares of £0.7m (2020: £nil). The cash receipt from the sale of the Haydock property of £3.5m will be recognised in the second half of the financial year.

 

- The first half of the year has seen an increase in revenue and profit, despite the on-going impact of Covid-19, Brexit, the China-USA trading challenges, volatile currency fluctuations and variable trading conditions.

 

- Ensuring that the business is Covid-19 secure for employees and visitors is paramount. As a critical supplier the Group continued to operate under strict Covid-19 Government guidelines.

 

- The newly developed extruded fire retardant click & fix product is expected to positively impact the business in the final quarter of this year.

 

- The sale of the land and building at Haydock completed on 19 November 2021 with the gain of approximately £0.9m being accounted for in the annual results to 30 April 2022.

 

 

 

Commenting on today's results, Joe Grimmond, Coral's Chairman, said:

 

"I am delighted with the performance of the business in the first half of the financial year. I am pleased to report that the results to date are well ahead of the same period last year, in spite of the prevailing uncertainties of Brexit and the Covid-19 pandemic. With our enhanced cash position arising from the sale of the Haydock property which completed on 19 November 2021 for £3.5m, we remain confident of the Group's future prospects".

 

 

 

 

Enquiries

 

Coral Products plc

Joe Grimmond, Executive Chairman

 

Tel: 07703 518 148

 

Nominated Adviser & Broker

WH Ireland Advisers LLP

Adrian Hadden, Darshan Patel, Megan Liddell

 

 

Tel: 020 7220 1751

Capital Markets Consultants Limited

Richard Pearson

Tel: 07515 587 184

 

Chairman's Statement

 

Results and Financial Position

 

Trading in the first half of the current year shows revenue substantially ahead of the same period for last year, with gross profit % decreasing slightly as a consequence of higher than usual transport and raw material costs. Reported revenue was £7,103,000 (six months to 31 October 2020: £4,531,000), gross margins were 35.7% (2020: 38.0%) resulting in a gross profit of £2,534,000 (2020: £1,720,000) in the six months to 31 October 2021. Underlying EBITDA was £1,014,000 (2020: £771,000). Underlying operating profits increased to £759,000 (2020: £563,000).

 

Separately disclosed expenses of £188,000 (2020: £208,000) comprised the amortisation of intangibles acquired on acquisition, share based payment charges over employee options and redundancy costs.

 

Finance costs dropped slightly to £61,000 (2020: £69,000).

 

Profit before tax after including all the above items was £510,000 (2020: £286,000).

 

The balance sheet net asset position remains strong at £12,376,000, net of £693,000 treasury shares (2020: £12,645,000). This represents a solid asset platform for developing the business.

 

The Group has cash and cash equivalents of £5,473,000 (2020: £1,292,000) which includes cash of £4,780,000 (2020: £1,292,000) and treasury shares of £693,000 (2020: £nil). This figure does not include the benefit of the cash receipts from the sale of the Haydock property in November 2021 of £3.5 million as this will be accounted for in the annual accounts.

 

The Group's net funds has increased to £1,677,000 (2020: £7,192,000 net debt).

Operations

Tatra-Rotalac Ltd

Tatra-Rotalac has exceeded the board's expectations during the first half of the financial year with sales and profits well above budget. The recent capital expenditure is expected to generate additional improvements to performance in the following six months.

Global One-Pak Ltd

This business has been hit especially hard during the six months to 31 October 2021 due to logistical cost increases in Chinese trading. This has been compounded by the continuing ill health of the managing director. The global shortage of containers, increased shipping times and delays at customs have all contributed to higher than usual transport costs.

Performance in the second half of the financial year is expected to improve given the business is now experiencing more enquiries as customers' stock levels are returning to pre-pandemic levels.

Customised Packaging Ltd

This business is experiencing strong demand in UK manufacturing. They currently have no supply issues and have assisted a major customer in recycling its end of life plastic.

Capital Expenditure

Total capital expenditure in the first six months was £375,000 (2020: £314,000) of which £375,000 (2020: £nil) related to Tatra-Rotalac.

 

 

 

Dividends

 

The board have declared an interim dividend of 0.50 pence per share (2020: 0.50p). The ex-dividend date and the record date for the interim dividend was 11 November 2021 and 12 November 2021 respectively. The interim dividend will be paid on 3 December 2021. This continues to reflect our confidence in the positive performance and profitable results of the Group.

 

 

Outlook

 

I am delighted with the performance of the business in the first half of the financial year. I am pleased to report that the results to date are well ahead of the same period last year, in spite of the prevailing uncertainties of Brexit and the Covid-19 pandemic. With our enhanced cash position arising from the sale of the Haydock property which completed on 19 November 2021 for £3.5m, we remain confident of the Group's future prospects.

Joe Grimmond Non-Executive Chairman 29 November 2021

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the six months to 31 October 2021

 

 

 

 

Notes

 

 

Six months to

31 October

2021

(unaudited)

 

£000

Six months to

31 October

2020

restated

(unaudited)

 

£000

Year to

30 April

2021

(audited)

 

£000

Revenue

3

 7,103

4,531

10,714

Cost of sales

 (4,569)

(2,811)

(6,913)

Gross profit

 2,534

1,720

3,801

Operating costs

Distribution expenses

(334)

(224)

 (761)

Administrative expenses before separately disclosed items

(1,441)

(933)

(2,173)

Underlying operating profit

 759

563

867

Separately disclosed items:

Share based payment credit/(charge)

 (25)

-

(8)

Amortisation of intangible assets

(163)

(138)

(284)

Reorganisation costs

 -

(70)

(780)

(188)

(208)

(1,072)

Operating profit/(loss)

 571

355

(205)

Finance expense

(61)

(69)

(111)

Profit/(loss) before taxation

510

286

(316)

Taxation

4

-

-

76

Total comprehensive income/(loss) on continuing operations

 510

286

(240)

Profit on discontinued operations

-

255

715

Total comprehensive income/(loss)

510

541

475

Earnings per ordinary share

5

Basic and diluted (pence)

0.59

0.35

(0.29)

Underlying basic (pence)

0.81

0.60

1.00

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

At 31 October 2021

 

 

 

31 October

2021

(unaudited)

 

£000

31 October

2020

(unaudited)

 

£000

30 April

2021

 (audited)

 

£000

Non-current assets

Goodwill

1,945

5,145

 1,945

Other intangible assets

 1,079

 986

1,243

Property, plant and equipment

1,133

2,768

630

Right of use assets

1,117

4,058

1,496

Total non-current assets

5,274

12,957

 5,314

Current assets

Inventories

1,752

3,395

1,828

Trade and other receivables

3,371

4,575

4,453

Cash and cash equivalents

4,780

1,292

3,843

Total current assets

9,903

9,262

10,124

Assets held for sale

2,500

2,520

2,500

Current liabilities

Bank overdrafts and borrowings

 (1,832)

 (2,526)

(1,353)

Trade and other payables

(1,906)

(3,212)

(2,039)

Lease liabilities

(405)

(1,393)

(459)

Corporation tax

-

-

-

Total current liabilities

(4,143)

(7,131)

(3,851)

Liabilities on assets held for sale

 -

 (1,706)

-

Non-current liabilities

Borrowings

-

(1,000)

-

Lease liabilities

(866)

(1,859)

(1,035)

Deferred taxation

(292)

(398)

(315)

Total non-current liabilities

(1,158)

(3,257)

(1,350)

Total liabilities

(5,301)

(12,094)

(5,201)

Total net assets

12,376

12,645

12,737

Equity

Share capital

859

826

859

Share premium

 5,621

 5,288

5,621

Treasury shares

(693)

-

(218)

Other reserves

1,567

1,567

1,567

Retained earnings

5,022

4,964

4,908

Total equity

 12,376

 12,645

12,737

CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY

 

For the six months to 31 October 2021 (unaudited)

 

Share

capital

Share

premium

Treasury shares

Other

reserves

Retained

earnings

Total

equity

 £000

 

£000

£000

£000

 £000

£000

At 1 May 2021

859

 5,621

(218)

1,567

4,908

12,737

Total comprehensive loss

-

-

-

-

510

510

Credit for share based payment

-

-

-

-

25

25

Purchase of treasury shares

-

-

(475)

-

-

(475)

Dividend paid

-

-

-

-

(421)

(421)

At 31 October 2021

859

5,621

(693)

1,567

5,022

12,376

 

 

 For the six months to 31 October 2020 (unaudited)

 

Share

capital

Share

premium

Treasury shares

Other

reserves

Retained

earnings

Total

equity

 £000

 

£000

£000

£000

 £000

£000

At 1 May 2020

826

5,288

-

1,567

4,425

12,106

Total comprehensive income

-

-

-

-

541

541

Charge for share based payment

-

-

-

-

(2)

(2)

At 31 October 2020

 826

 5,288

-

1,567

 4,964

12,645

 

For the year ended 30 April 2021 (audited)

 

Share

capital

Share

premium

Treasury shares

Other

reserves

Retained

earnings

Total

equity

 £000

 

£000

£000

£000

 £000

£000

At 1 May 2020

826

 5,288

-

1,567

4,425

12,106

Total comprehensive profit

-

-

-

-

475

475

Credit for share based payment

-

-

-

-

8

8

Issue of new shares

33

333

-

-

-

366

Purchase of treasury shares

-

-

(218)

-

-

(218)

At 30 April 2021

859

5,621

(218)

1,567

4,908

12,737

 

 

 

 

 

CONSOLIDATED STATEMENT OF CASH FLOWS

For the six months to 31 October 2021

Six months to

31 October

2021

(unaudited)

£000

Six months to

31 October

2020

(unaudited)

£000

Year to

30 April

2021

(audited)

£000

Cash flow from operating activities

Profit for the period after tax

510

541

475

Adjustments for:

Depreciation of property, plant and equipment

122

321

487

Depreciation of right of use assets under IFRS16

133

307

666

Amortisation of intangible assets

163

138

284

Share based payment (credit)/charge

25

(2)

8

Profit on disposal of subsidiary

-

-

(1,133)

Interest payable

 61

 223

329

Taxation charge/(credit)

-

-

(48)

(Increase)/decrease in inventories

76

(27)

(382)

Decrease/(increase) in trade and other receivables

505

386

433

(Decrease)/increase in trade and other payables

(133)

(537)

422

UK corporation tax received

-

-

299

Net cash generated from operating activities

1,462

1,350

1,840

Cash flow from investing activities

Net cash on disposal of subsidiary

-

-

7,771

Acquisition of subsidiary

-

-

(937)

Acquisition of property, plant and equipment

(375)

(314)

(454)

Net cash (used in)/generated from investing activities

(375)

(314)

6,380

Cash flow from financing activities

Interest paid on bank borrowings and invoice discounting

(61)

(223)

(119)

Interest paid on lease liabilities

-

-

(210)

Repayments of bank borrowings

-

 (60)

(2,765)

Repayments of obligations under lease liabilities

(93)

(462)

(893)

Purchase of treasury shares

(475)

-

(218)

New bank loans raised

-

1,000

1,000

Movements on invoice discounting facility

479

(452)

(1,625)

Net cash used in financing activities

(150)

(197)

 (4,830)

Net increase in cash and cash equivalents

937

839

3,390

Cash and cash equivalents at the start of the period

3,843

453

453

Cash and cash equivalents at the end of the period

4,780

1,292

3,843

 

1. Basis of preparation

 

The financial information set out in this Interim Report does not constitute statutory accounts as defined in Section 435 of the Companies Act 2006.

 

The Group's statutory financial statements for the year ended 30 April 2021, prepared under IFRS, have been filed with the Registrar of CompaniesThe auditor's report on those statutory accounts was qualified with respect to opening inventory as the audit evidence available was limited because, given the global Covid-19 pandemic, no inventory count was undertaken and the auditor did not observe the physical inventory as at 30 April 2020.

 

The interim financial information has been prepared in accordance with the recognition and measurement principles of International Financial Reporting Standards (IFRS) and on the same basis and using the same accounting policies as used in the financial statements for the year ended 30 April 2021.

 

The Interim Report has not been reviewed by our auditor in accordance with the International Standard on Review Engagement 2410 issued by the Auditing Practices Board.

 

 

2. Significant accounting policies

 

The accounting policies applied by the Group in these condensed consolidated interim financial statements are the same as those applied by the Group in its consolidated financial statements for the year ended 30 April 2021.

 

The six months to 31 October 2020 have been restated to show the results of continuing operations only.

 

 

3. Revenue

 

All production is based in the United Kingdom. The geographical analysis of revenue is shown below:

 

Six months to

31 October 2021

(unaudited)

£000

Six months to

31 October 2020

restated

(unaudited)

£000

Year to

30 April 2021

(audited)

£000

United Kingdom

 6,827

 4,050

9,811

Rest of Europe

186

386

94

Rest of the World

90

95

809

 7,103

 4,531

10,714

Turnover by business activity

Sale and manufacture of plastic products

 7,103

 4,531

10,714

 

 

 

4. Taxation

 

The taxation charge for the six months to 31 October 2021 is based on the effective taxation rate, which is estimated will apply to earnings for the year ending 30 April 2022. The rate used is below the applicable UK corporation tax rate of 19% due to the utilisation of tax losses in the period.

 

 

5. Earnings per share

 

Basic and underlying earnings per ordinary share are calculated using the weighted average number of ordinary shares in issue during the financial period of 85,942,534 (31 October 2020: 82,614,865 and 30 April 2021: 83,032,453).

 

 

 

Six months to

31 October 2021

(unaudited)

 

Six months to

31 October 2020

(unaudited)

restated

 

Year to

30 April

2021

(audited)

 

£000

p

£000

p

£000

p

Basic and diluted earnings per ordinary share

Profit/(loss) for the period after tax

 510

0.59

 286

0.35

(240)

(0.29)

 

 

Underlying earnings per ordinary share

Underlying profit/(loss) for the period after tax

 698

0.81

 494

0.60

832

1.00

 

 

6. Movement in Net Debt

 

Net debt incorporates the Group's borrowings and bank overdrafts less cash and cash equivalents. A reconciliation of the movement in the net debt is shown below:

 

Six months to

31 October

2021

 (unaudited)

 

£000

Six months to

31 October

2020

(unaudited)

 

£000

Year to

30 April

2021

(audited)

 

 £000

Net increase in cash and cash equivalents

 458

 839

5,015

Decrease/(increase) in bank and other loans

-

510

1,765

(Decrease)/increase in lease liabilities

223

(551)

2,206

Movement in net debt in the financial period

681

798

8,986

Net funds/(debt) at beginning of period

996

(7,990)

(7,990)

Net funds/(debt) at end of period

 1,677

 (7,192)

996

 

 

 

 

 

 

 

7. Underlying profit and separately disclosed items

 

Underlying profit before tax, underlying earnings per share, underlying operating profit, underlying earnings before interest, tax, depreciation and amortisation are defined as being before share based payment charges, amortisation of intangibles recognised on acquisition, acquisition costs, reorganisation costs, compensation for loss of office, impairment of goodwill and impairment loss on trade receivables. Collectively these are referred to as separately disclosed items. In the opinion of the directors the disclosure of these transactions should be reported separately for a better understanding of the underlying trading performance of the Group.

 

Six months to

31 October

2021

 (unaudited)

 

£000

Six months to

31 October

2020

(unaudited)

 

£000

Year to

 30 April

2021

(audited)

 

 £000

Operating profit/(loss)

 571

 355

(205)

Separately disclosed items within administration expenses

Share based payment (credit)/charge

25

-

8

Amortisation of intangible assets

163

138

284

Reorganisation costs

-

70

780

Total separately disclosed items

 188

208

1,072

Underlying operating profit

759

563

867

Depreciation

255

208

417

Underlying EBITDA

1,014

771

1,284

 

 

 

8. Forward looking statements

 

This announcement contains unaudited information and forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts and undue reliance should not be placed on any such statement because they speak only as at the date of this document and are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Coral's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements. Coral undertakes no obligation to revise or update any forward-looking statement contained within this announcement, regardless of whether those statements are affected as a result of new information, future events or otherwise, save as required by law and regulations.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (MAR). The Directors of the Group take responsibility for this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR GRBDBBUDDGBC
Date   Source Headline
1st Feb 20247:00 amRNSDirector/PDMR Shareholding
26th Jan 20247:00 amRNSTrading Statement
11th Dec 20237:00 amRNSHalf-year Report
29th Nov 20237:00 amRNSTrading Update and Directorate Change
7th Nov 20237:00 amRNSChange of Nominated Adviser and Broker
13th Oct 20235:21 pmRNSTransaction in Own Shares
12th Oct 20235:22 pmRNSTransaction in Own Shares
11th Oct 20235:52 pmRNSTransaction in Own Shares
5th Oct 20235:27 pmRNSTransaction in Own Shares
2nd Oct 20235:34 pmRNSTransaction in Own Shares
27th Sep 20232:05 pmRNSResult of General Meeting
27th Sep 20237:00 amRNSTrading Statement
8th Sep 20235:07 pmRNSNotice of AGM and Posting of Annual Report
4th Sep 20237:00 amRNSFinal Results
12th Jul 20235:39 pmRNSTransaction in Own Shares
10th Jul 20235:43 pmRNSTransaction in Own Shares
10th Jul 202311:36 amRNSShare Buyback Programme
4th Jul 20237:00 amRNSAcquisition Update
24th May 20237:00 amRNSTrading Statement
15th Mar 20237:00 amRNSNew Group Banking Facilities
6th Mar 20234:35 pmRNSPrice Monitoring Extension
6th Mar 20232:00 pmRNSPrice Monitoring Extension
7th Feb 202311:46 amRNSHolding(s) in Company
17th Jan 20235:21 pmRNSConfirmation of Capital Reduction
14th Dec 20222:08 pmRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSInterim Results
8th Dec 202212:00 pmRNSNotice of Interim Results & Investor Presentation
2nd Dec 20227:00 amRNSDirectorate Change
30th Nov 20225:38 pmRNSResult of Meeting
4th Nov 20223:10 pmRNSNotice of General Meeting-Publication of Circular
4th Nov 202212:41 pmRNSHolding(s) in Company
28th Oct 20227:00 amRNSIssue of Equity
13th Oct 20222:23 pmRNSDirector/PDMR Shareholding
13th Oct 20228:41 amRNSDirector/PDMR Shareholding
12th Oct 20227:00 amRNSAcquisition of Ecodeck Grids Limited
7th Oct 20227:00 amRNSTransaction in Own Shares
29th Sep 20223:14 pmRNSResult of AGM and GM
29th Sep 20227:00 amRNSAGM Statement
19th Sep 20227:00 amRNSAcquisition of Manplas Holdings Limited
7th Sep 20227:00 amRNSPosting of Annual Report, Notice of AGM and GM
7th Sep 20227:00 amRNSFinal results for year ended 30 April 2022
2nd Sep 20227:00 amRNSChange of Adviser
10th Jun 20227:00 amRNSPDMR/Director Dealings
8th Jun 20227:00 amRNSTrading Update and Proposed Dividend
31st May 20229:06 amRNSTransaction in Own Shares
30th May 20227:00 amRNSAcquisition of Alma Products Limited
16th May 20224:24 pmRNSTR-1: Notification of major holdings
16th May 20221:22 pmRNSTransaction in Own Shares
4th May 20229:22 amRNSAcquisition of Film & Foil Solutions Limited
25th Apr 20224:26 pmRNSAppointment of Group Operations Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.